StonvexLoading…
StonvexStonvexStonvexCore line items from PB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $392.36M | $441.77M | $1.57B | $1.18B | $785.57M |
Operating Income | Not available | $150.34M | $693.58M | $514.56M | $338.52M |
Net Income | Not available | $116.27M | $542.84M | $402.94M | $265.38M |
EPS (Diluted) | $1.53 | $1.16 | $5.72 | $4.23 | $2.79 |
Total Assets | Not available | $43.62B | $38.46B | $38.33B | $38.42B |
Total Liabilities | Not available | $35.41B | $30.85B | $30.67B | $30.82B |
Cash & Equivalents | Not available | Not available | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | Not available | $178.10M | $516.98M | $448.53M | $262.86M |
Shares Outstanding | Not available | 100.84M | 93.06M | 94.99M | 95.28M |